ACR–NASCI–SPR PRACTICE PARAMETER FOR THE PERFORMANCE AND INTERPRETATION OF CARDIAC MAGNETIC RESONANCE IMAGING (MRI)

1. Krishnamurthy RR, Cheong BB, Muthupillai RR. Tools for cardiovascular magnetic resonance imaging. Cardiovasc Diagn Ther 4:104-25, .
2. Ripley DD, Motwani MM, Plein SS, Greenwood JJ. Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg 4:330-44, .
3. Sohns JM, Schwarz A, Menke J, et al. Prevalence and clinical relevance of extracardiac findings at cardiac MRI. J Magn Reson Imaging. 39(1):68-76, 2014 Jan.
4. Karius PP, Schuetz GG, Schlattmann PP, Dewey MM. Extracardiac findings on coronary CT angiography: a systematic review. J Cardiovasc Comput Tomogr 8:174-82.e1-6, .
5. Mahani MM, Morani AA, Lu JJ, et al. Non-cardiovascular findings in clinical cardiovascular magnetic resonance imaging in children. Pediatr Radiol 46:473-82, .
6. Wollmann CC, Thudt KK, Kaiser BB, Salomonowitz EE, Mayr HH, Globits SS. Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study. J Cardiovasc Magn Reson 16:30, .
7. Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011; 155(7):415-424.
8. Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. [Review]. Heart Rhythm. 14(7):e97-e153, 2017 07.
9. American College of Radiology. ACR Practice Parameter for Performing and Interpreting Magnetic Resonance Imaging (MRI). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=146+&releaseId=2
10. American College of Radiology. ACR Committee on Drugs and Contrast Media. Manual on Contrast Media.  Available at: https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Contrast-Manual.
11. Simonetti OO, Finn JJ, White RR, Laub GG, Henry DD. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 199:49-57, .
12. Kunz RR, Oellig FF, Krummenauer FF, et al. Assessment of left ventricular function by breath-hold cine MR imaging: Comparison of different steady-state free precession sequences. J Magn Reson Imaging 21:140-8, .
13. Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation.2009;119(3):468-478.
14. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001 Apr;219(1):264-9.
15. Moon JC, Lorenz CH, Francis JM, Smith GC, Pennell DJ. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology. 2002 Jun;223(3):789-97.
16. Kacere RR, Pereyra MM, Nemeth MM, Muthupillai RR, Flamm SS. Quantitative assessment of left ventricular function: steady-state free precession MR imaging with or without sensitivity encoding. Radiology 235:1031-5, .
17. Messroghli DD, Bainbridge GG, Alfakih KK, et al. Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging. Radiology 235:229-36, .
18. Castillo EE, Lima JJ, Bluemke DD. Regional myocardial function: advances in MR imaging and analysis. Radiographics 23 Spec No:S127-40, .
19. Kar JJ, Knutsen AA, Cupps BB, Pasque MM. A validation of two-dimensional in vivo regional strain computed from displacement encoding with stimulated echoes (DENSE), in reference to tagged magnetic resonance imaging and studies in repeatability. Ann Biomed Eng 42:541-54, .
20. Pan LL, Stuber MM, Kraitchman DD, Fritzges DD, Gilson WW, Osman NN. Real-time imaging of regional myocardial function using fast-SENC. Magn Reson Med 55:386-95, .
21. Myerson SS. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:7, .
22. Hsiao AA, Tariq UU, Alley MM, Lustig MM, Vasanawala SS. Inlet and outlet valve flow and regurgitant volume may be directly and reliably quantified with accelerated, volumetric phase-contrast MRI. J Magn Reson Imaging 41:376-85, .
23. Schwitter J, Wacker CM, Wilke N, et al. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial). J Cardiovasc Magn Reson. 2012;14:61.
24. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379(9814):453-460.
25. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999 Nov 09;100(19):1992-2002.
26. El Aidi HH, Adams AA, Moons KK, et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol 63:1031-45, .
27. Cummings KK, Bhalla SS, Javidan-Nejad CC, Bierhals AA, Gutierrez FF, Woodard PP. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 29:89-103, .
28. Ordovas KK, Higgins CC. Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology 261:358-74, .
29. Becker MM, Cornel JJ, van de Ven PP, van Rossum AA, Allaart CC, Germans TT. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC Cardiovasc Imaging 11:1274-1284, .
30. Weng ZZ, Yao JJ, Chan RR, et al. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. JACC Cardiovasc Imaging 9:1392-1402, .
31. Di Marco A, Anguera I, Schmitt M, et al. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. [Review]. JACC Heart Fail. 5(1):28-38, 2017 01.
32. Yue TT, Chen BB, Wu LL, Xu JJ, Pu JJ. Prognostic Value of Late Gadolinium Enhancement in Predicting Life-Threatening Arrhythmias in Heart Failure Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis. J Magn Reson Imaging 51:1422-1439, .
33. Yang FF, Wang JJ, Li WW, et al. The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis. Eur Radiol 30:2616-2626, .
34. Coleman GC, Shaw PW, Balfour PC Jr, et al. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. [Review]. Jacc: Cardiovascular Imaging. 10(4):411-420, 2017 04.
35. Naßenstein KK, Nensa FF, Schlosser TT, et al. Cardiac MRI: T2-Mapping Versus T2-Weighted Dark-Blood TSE Imaging for Myocardial Edema Visualization in Acute Myocardial Infarction. Rofo 186:166-72, .
36. Kotanidis CC, Bazmpani MM, Haidich AA, Karvounis CC, Antoniades CC, Karamitsos TT. Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging 11:1583-1590, .
37. Baksi AJ, Pennell DJ. T2* imaging of the heart: methods, applications, and outcomes. [Review]. Topics in Magnetic Resonance Imaging. 23(1):13-20, 2014 Feb.
38. Sibley CC, Noureldin RR, Gai NN, et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 265:724-32, .
39. Hamdan AA, Charalampos KK, Roettgen RR, et al. Magnetic resonance imaging versus computed tomography for characterization of pulmonary vein morphology before radiofrequency catheter ablation of atrial fibrillation. Am J Cardiol 104:1540-6, .
40. Raman FF, Nacif MM, Cater GG, et al. 3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium. Int J Cardiovasc Imaging 29:1085-94, .
41. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002 Jul 01;90(1):29-34.
42. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.
43. Douglas PP, Hendel RR, Cummings JJ, et al. ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR 2008 Health Policy Statement on Structured Reporting in Cardiovascular Imaging. J Am Coll Cardiol 53:76-90, .
44. Hudsmith LL, Petersen SS, Francis JJ, Robson MM, Neubauer SS. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7:775-82, .
45. Marcus FF, McKenna WW, Sherrill DD, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121:1533-41, .
46. te Riele AA, Bhonsale AA, James CC, et al. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 62:1761-9, .
47. Kawut SS, Al-Naamani NN, Agerstrand CC, et al. Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest 135:752-759, .
48. Ley S, Mereles D, Puderbach M, et al. Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol. 2007;17(7):1892-1897.
49. Lipinski MM, McVey CC, Berger JJ, Kramer CC, Salerno MM. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol 62:826-38, .
50. Lockie T, Nagel E, Redwood S, Plein S. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. [Review] [104 refs]. Circulation. 119(12):1671-81, 2009 Mar 31.
51. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001 Sep 04;104(10):1101-7.
52. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475-1487.
53. Lim RR, Srichai MM, Lee VV. Non-ischemic causes of delayed myocardial hyperenhancement on MRI. AJR Am J Roentgenol 188:1675-81, .
54. Machii MM, Satoh HH, Shiraki KK, et al. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome. Magn Reson Imaging 32:118-24, .
55. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003 Jul 08;108(1):54-9.
56. Camastra GG, Cacciotti LL, Marconi FF, Sbarbati SS, Pironi BB, Ansalone GG. Late enhancement detected by cardiac magnetic resonance imaging in acute myocarditis mimicking acute myocardial infarction: location patterns and lack of correlation with systolic function. J Cardiovasc Med (Hagerstown) 8:1029-33, .
57. Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology. 237(1):75-82, 2005 Oct.
58. Crawford T, Mueller G, Sarsam S, et al. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circulation: Arrhythmia and Electrophysiology. 7(6):1109-15, 2014 Dec.
59. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000 Nov 16;343(20):1445-53.
60. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. [Review]. J Am Coll Cardiol. 72(24):3158-3176, 2018 12 18.
61. Bogaert JJ, Olivotto II. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside. Radiology 273:329-48, .
62. Westwood MA, Wonke B, Maceira AM, et al. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major. J Magn Reson Imaging. 2005; 22(2):229-233.
63. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111(2):186-193.
64. Futamatsu HH, Wilke NN, Klassen CC, et al. Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant coronary artery disease. Am Heart J 154:298-305, .
65. Abbasi SS, Heydari BB, Shah RR, et al. Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery disease. Am J Cardiol 114:1198-203, .
66. Chung SS, Lee KK, Chun EE, et al. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. AJR Am J Roentgenol 195:356-62, .
67. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 29(4):480-9, 2008 Feb.
68. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34(10):775-781.
69. Noel CC, Krishnamurthy RR, Moffett BB, Krishnamurthy RR, Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson. Pediatr Radiol 47:280-289, .
70. Greenwood JJ, Ripley DD, Berry CC, et al. Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. JAMA 316:1051-60, .
71. Nagel E, Greenwood JP, McCann GP, et al. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med 2019;380:2418-28.
72. Kwong RY, Ge Y, Steel K, et al. Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain. Journal of the American College of Cardiology. 74(14):1741-1755, 2019 10 08.J Am Coll Cardiol. 74(14):1741-1755, 2019 10 08.
73. Charoenpanichkit C, Hundley WG. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. [Review]. J Cardiovasc Magn Reson. 12:59, 2010 Oct 26.
74. Pujadas SS, Reddy GG, Weber OO, Lee JJ, Higgins CC. MR imaging assessment of cardiac function. J Magn Reson Imaging 19:789-99, .
75. Potter DD, Araoz PP, McGee KK, Harmsen WW, Mandrekar JJ, Sundt TT. Low-dose dobutamine cardiac magnetic resonance imaging with myocardial strain analysis predicts myocardial recoverability after coronary artery bypass grafting. J Thorac Cardiovasc Surg 135:1342-7, .
76. Badger TT, Daccarett MM, Akoum NN, et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol 3:249-59, .
77. Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006;152:75-84.
78. Pazos-Lopez P, Pozo E, Siqueira ME, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 7(9):896-905, 2014 Sep.
79. Esposito AA, De Cobelli FF, Ironi GG, et al. CMR in assessment of cardiac masses: primary benign tumors. JACC Cardiovasc Imaging 7:733-6, .
80. Beroukhim RS, Prakash A, Buechel ER, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 58(10):1044-54, 2011 Aug 30.
81. Alraies MC, AlJaroudi W, Yarmohammadi H, et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. American Journal of Cardiology. 115(4):542-7, 2015 Feb 15.Am J Cardiol. 115(4):542-7, 2015 Feb 15.
82. Axel LL. Assessment of pericardial disease by magnetic resonance and computed tomography. J Magn Reson Imaging 19:816-26, .
83. Wang ZZ, Reddy GG, Gotway MM, Yeh BB, Hetts SS, Higgins CC. CT and MR imaging of pericardial disease. Radiographics 23 Spec No:S167-80, .
84. Meltser HH, Kalaria VV. Cardiac tamponade. Catheter Cardiovasc Interv 64:245-55, .
85. Caruthers SS, Lin SS, Brown PP, et al. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation 108:2236-43, .
86. Didier D, Ratib O, Lerch R, Friedli B. Detection and quantification of valvular heart disease with dynamic cardiac MR imaging. Radiographics. 2000;20(5):1279-99; discussion 1299-301.
87. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001 Dec 27;345(26):1863-9.
88. Yang Q, Li K, Liu X, et al. 3.0T whole-heart coronary magnetic resonance angiography performed with 32-channel cardiac coils: a single-center experience. Circ Cardiovasc Imaging. 2012;5(5):573-579.
89. Piaw CC, Kiam OO, Rapaee AA, et al. Use of non-invasive phase contrast magnetic resonance imaging for estimation of atrial septal defect size and morphology: a comparison with transesophageal echo. Cardiovasc Intervent Radiol 29:230-4, .
90. Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation. 1995;91(12):2955-2960.
91. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218-23.
92. Haggerty CC, Restrepo MM, Tang EE, et al. Fontan hemodynamics from 100 patient-specific cardiac magnetic resonance studies: a computational fluid dynamics analysis. J Thorac Cardiovasc Surg 148:1481-9, .
93. Lu JJ, Dorfman AA, Attili AA, Ghadimi Mahani MM, Dillman JJ, Agarwal PP. Evaluation with cardiovascular MR imaging of baffles and conduits used in palliation or repair of congenital heart disease. Radiographics 32:E107-27, .
94. Lewis MJ, O'Connor DS, Rozenshtien A, et al. Usefulness of magnetic resonance imaging to guide referral for pulmonary valve replacement in repaired tetralogy of Fallot. American Journal of Cardiology. 114(9):1406-11, 2014 Nov 01.Am J Cardiol. 114(9):1406-11, 2014 Nov 01.
95. Oosterhof TT, van Straten AA, Vliegen HH, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116:545-51, .
96. Brown DD, Gauvreau KK, Powell AA, et al. Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional glenn anastomosis in infants with functional single ventricle: a prospective randomized trial. Circulation 116:2718-25, .
97. Fogel MM, Pawlowski TT, Whitehead KK, et al. Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. J Am Coll Cardiol 60:1094-102, .
98. Devos DD, Kilner PP. Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements. Eur Radiol 20:410-21, .
99. Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology. 2003 Apr;227(1):201-8.
100. Mavrogeni S, Papadopoulos G, Hussain T, Chiribiri A, Botnar R, Greil GF. The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. [Review]. Int J Cardiovasc Imaging. 29(8):1787-98, 2013 Dec.
101. American College of Radiology. ACR-NASCI-SPR Practice Parameter for the Performance of Body Magnetic Resonance Angiography (MRA). Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=69+&releaseId=2
102. American College of Radiology. ACR Practice Parameter for Continuing Medical Education. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=130+&releaseId=2
103. American Registry of Radiologic Technologists. Continuing Education Requirements for Renewal of Registration. https://www.arrt.org/.
104. Expert Panel on MR Safety, Kanal E, Barkovich AJ, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 37(3):501-30, 2013 Mar.
105. Cohen JJ, Costa HH, Russo RR. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol 110:1631-6, .
106. American College of Radiology. ACR–SPR Practice Parameter for the use of Intravascular Contrast Media. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=142+&releaseId=2
107. Cutter TT. Radiologists and anesthesiologists. Anesthesiol Clin 27:95-106, .
108. American College of Radiology. ACR–SIR Practice Parameter For Minimal and/or Moderate Sedation/Analgesia. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=95+&releaseId=2
109. Shariat MM, Mertens LL, Seed MM, et al. Utility of feed-and-sleep cardiovascular magnetic resonance in young infants with complex cardiovascular disease. Pediatr Cardiol 36:809-12, .
110. American College of Radiology. ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Magnetic Resonance (MR) Imaging Equipment. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=57+&releaseId=2
111. Sawyer-Glover AM, Shellock FG. Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices. J Magn Reson Imaging. 2000 Sep;12(3):510.
112. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002 Feb;47(2):372-83.
113. Schubert TT, Bieri OO, Pansini MM, Stippich CC, Santini FF. Peak velocity measurements in tortuous arteries with phase contrast magnetic resonance imaging: the effect of multidirectional velocity encoding. Invest Radiol 49:189-94, .
114. Pasqua AA, Barcudi SS, Leonardi BB, Clemente DD, Colajacomo MM, Sanders SS. Comparison of contrast and noncontrast magnetic resonance angiography for quantitative analysis of thoracic arteries in young patients with congenital heart defects. Ann Pediatr Cardiol 4:36-40, .
115. Axel LL, Otazo RR. Accelerated MRI for the assessment of cardiac function. Br J Radiol 89:20150655, .
116. American College of Radiology. ACR Practice Parameter for Communication of Diagnostic Imaging Findings. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=74+&releaseId=2